by Nicolas Hulscher, MPH Fenbendazole (FBZ) is a low-cost veterinary antiparasitic drug that has gained global attention as a potential anticancer therapy. Like ivermectin—another antiparasitic widely repurposed in research and clinical practice for its potent anti-tumor effects—fenbendazole appears to work far beyond its original veterinary use. Preclinical studies show fenbendazole disrupts cancer cell survival through … Continue reading NEW STUDY: Fenbendazole Linked to Remission or Near-Remission in Three Stage IV Cancer Patients